82 related articles for article (PubMed ID: 32943616)
1. DRAM1 plays a tumor suppressor role in NSCLC cells by promoting lysosomal degradation of EGFR.
Geng J; Zhang R; Yuan X; Xu H; Zhu Z; Wang X; Wang Y; Xu G; Guo W; Wu J; Qin ZH
Cell Death Dis; 2020 Sep; 11(9):768. PubMed ID: 32943616
[TBL] [Abstract][Full Text] [Related]
2. DRAM1 regulates autophagy flux through lysosomes.
Zhang XD; Qi L; Wu JC; Qin ZH
PLoS One; 2013; 8(5):e63245. PubMed ID: 23696801
[TBL] [Abstract][Full Text] [Related]
3. A leak pathway for luminal protons in endosomes drives oncogenic signalling in glioblastoma.
Kondapalli KC; Llongueras JP; Capilla-González V; Prasad H; Hack A; Smith C; Guerrero-Cázares H; Quiñones-Hinojosa A; Rao R
Nat Commun; 2015 Feb; 6():6289. PubMed ID: 25662504
[TBL] [Abstract][Full Text] [Related]
4. DRAM1 increases the secretion of PKM2-enriched EVs from hepatocytes to promote macrophage activation and disease progression in ALD.
Tan J; Zhang J; Wang M; Wang Y; Dong M; Ma X; Sun B; Liu S; Zhao Z; Chen L; Jin W; Liu K; Xin Y; Zhuang L
Mol Ther Nucleic Acids; 2022 Mar; 27():375-389. PubMed ID: 35036051
[TBL] [Abstract][Full Text] [Related]
5. Jinfukang inhibits clustering and invasion of circulating lung tumor cells by regulating the EGFR signaling pathway.
Yang Y; Zhu L; Liu J; Yu P; Que Z; Li Y; Li H; Tian J
Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1851-1854. PubMed ID: 37723875
[No Abstract] [Full Text] [Related]
6. DNA Damage-Regulated Autophagy Modulator 1 (DRAM1) Mediates Autophagy and Apoptosis of Intestinal Epithelial Cells in Inflammatory Bowel Disease.
Zhang Y; Li X; Li Y; Li Y; Wang Y; Zhu L; Chen P; Tian Z; Qiu Y; Feng R; Zeng Z; He Y; Chen B; Zhang S; Mao R; Chen M
Dig Dis Sci; 2021 Oct; 66(10):3375-3390. PubMed ID: 33184797
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of ATP6V1s Family Members in Renal Clear Cell Carcinoma With Prognostic Values.
Li X; Li H; Yang C; Liu L; Deng S; Li M
Front Oncol; 2020; 10():567970. PubMed ID: 33194650
[TBL] [Abstract][Full Text] [Related]
8. Cereblon Promotes the Ubiquitination and Proteasomal Degradation of Interleukin Enhancer-Binding Factor 2.
Lian Q; Gao Y; Li Q; He X; Jiang X; Pu Z; Xu G
Protein J; 2020 Oct; 39(5):411-421. PubMed ID: 33009960
[TBL] [Abstract][Full Text] [Related]
9. DRAM1 plays a tumor suppressor role in clear cell renal cell carcinoma through modulating Akt signaling.
Feng Q; Cheng M; Jin J; Zhang S; Bai Y; Xu J
Acta Histochem; 2022 Apr; 124(3):151874. PubMed ID: 35299128
[TBL] [Abstract][Full Text] [Related]
10. Targeting dysregulated phago-/auto-lysosomes in Sertoli cells to ameliorate late-onset hypogonadism.
Deng Z; Zhao L; Li S; Chen X; Ling X; Zheng J; Yu K; Xu J; Yao C; Han S; Liang J; Feng H; Wu L; Li P; Tian R; Jing T; Tang Y; Dai Y; Yan M; Wang C; Li Z; Zhou Z
Nat Aging; 2024 May; 4(5):647-663. PubMed ID: 38649614
[TBL] [Abstract][Full Text] [Related]
11. Xenophagy receptors Optn and p62 and autophagy modulator Dram1 independently promote the zebrafish host defense against
Xie J; Meijer AH
Front Cell Infect Microbiol; 2023; 13():1331818. PubMed ID: 38264729
[TBL] [Abstract][Full Text] [Related]
12. Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer.
Zhou J; Li H; Wu B; Zhu L; Huang Q; Guo Z; He Q; Wang L; Peng X; Guo T
Sci Rep; 2024 Jan; 14(1):1860. PubMed ID: 38253629
[TBL] [Abstract][Full Text] [Related]
13. Investigating the Association between the Autophagy Markers LC3B,
Danish F; Qureshi MA; Mirza T; Amin W; Sufiyan S; Naeem S; Arshad F; Mughal N
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203743
[TBL] [Abstract][Full Text] [Related]
14. Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin.
Xin Y; Jiang Q; Liu C; Qiu J
Aging (Albany NY); 2023 Nov; 15(21):12225-12250. PubMed ID: 37925175
[TBL] [Abstract][Full Text] [Related]
15. ARHGAP4 promotes leukemogenesis in acute myeloid leukemia by inhibiting DRAM1 signaling.
Qi Y; Hu M; Han C; Wang J; Chen F; Guo H; She Y; Zhang M; Zhang J; Zhao Z; Xie H; Wang S; Chen M; Wang J; Zeng D
Oncogene; 2023 Aug; 42(34):2547-2557. PubMed ID: 37443303
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor (EGFR) expression in the serum of patients with triple-negative breast carcinoma: prognostic value of this biomarker.
de Araújo RA; da Luz FAC; da Costa Marinho E; Nascimento CP; de Andrade Marques L; Delfino PFR; Antonioli RM; Araújo BJ; da Silva ACAL; Dos Reis Monteiro MLG; Neto MB; Silva MJB
Ecancermedicalscience; 2022; 16():1431. PubMed ID: 36158981
[TBL] [Abstract][Full Text] [Related]
17. Autophagy-Related Gene Signature Highlights Metabolic and Immunogenic Status of Malignant Cells in Non-Small Cell Lung Cancer Adenocarcinoma.
Leonardi L; Siberil S; Alifano M; Cremer I; Joubert PE
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884522
[TBL] [Abstract][Full Text] [Related]
18. The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma.
Li X; Dai Z; Wu X; Zhang N; Zhang H; Wang Z; Zhang X; Liang X; Luo P; Zhang J; Liu Z; Zhou Y; Cheng Q; Chang R
Front Immunol; 2022; 13():749241. PubMed ID: 35529878
[TBL] [Abstract][Full Text] [Related]
19. EGFR-AS1 Promotes Nonsmall Cell Lung Cancer (NSCLC) Progression via Downregulating the miR-524-5p/DRAM1 Axis and Inhibiting Autophagic Lysosomal Degradation.
Xue Y; Zhang J; Hou J; Wang X
J Oncol; 2022; 2022():4402536. PubMed ID: 35222643
[TBL] [Abstract][Full Text] [Related]
20. Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer.
Zheng M; Hu Y; Gou R; Li S; Nie X; Li X; Lin B
Mol Ther Oncolytics; 2021 Sep; 22():294-306. PubMed ID: 34553020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
